BBSRC is not responsible for the content of external websites
DNA sequencing spin-out sells for $600M
5 February 2007
Solexa, a spin-out company from the University of Cambridge, formed in 1998 and inspired from some basic research funded by BBSRC, was sold to US-based Illumina for $600M in January 2007.
The research by Dr Shankar Balasubramanian and Dr David Klenerman on DNA chemistry led to novel sequencing and detection systems which the scientists commercialised through Solexa.
External Relations Unit